Additionally, further investigations have identified a set of androgen-responsive genes such as transglutaminase 4 (TGM4) that could serve as potential tumor-associated antigens (TAAs) for prostate cancer [3]. The gene discussed is TGM4; the disease is prostate carcinoma.